Green Thumb Industries (GTBIF) Capital Expenditures (2019 - 2026)
Green Thumb Industries' (GTBIF) quarterly Capital Expenditures came in at $18.9 million in Q1 2026, down 36.81% YoY from $29.8 million in Q1 2025, and up 28.45% on a QoQ basis from $14.7 million in Q4 2025.
Green Thumb Industries (GTBIF) Capital Expenditures (2019 - 2026) Analysis & Trends
Green Thumb Industries (GTBIF) has 8 years of Capital Expenditures data on file, last reported at $18.9 million in Q1 2026.
- Quarterly Capital Expenditures fell 36.81% year-over-year to $18.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $70.1 million (down 26.47% YoY) and the FY2025 annual result came in at $81.1 million, up 1.1% from the prior year.
- Capital Expenditures grew to $18.9 million in Q1 2026, from $14.7 million in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $65.0 million in Q1 2023 to a low of $14.3 million in Q2 2022.
- A 5-year average of $34.1 million and a median of $27.2 million in 2024 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2023 — Capital Expenditures jumped 350.23% — and 2024, when it sank 77.37%.
- Tracing GTBIF's Capital Expenditures over 5 years: stood at $59.6 million in 2022, then sank by 38.89% to $36.4 million in 2023, then retreated by 25.37% to $27.2 million in 2024, then slumped by 46.02% to $14.7 million in 2025, then increased by 28.45% to $18.9 million in 2026.
- The last three Capital Expenditures figures came in at $18.9 million (Q1 2026), $14.7 million (Q4 2025), and $17.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Green Thumb Industries | 1.65 Bn | 1.37 Bn | 137.87 Mn | 20.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.22 Mn |
| Jun 30, 2026 | 20.22 Mn |
| Mar 31, 2026 | 18.86 Mn |
| Mar 31, 2026 | 18.86 Mn |
| Dec 31, 2025 | 14.68 Mn |
| Dec 31, 2025 | 14.68 Mn |
| Sep 30, 2025 | 17.55 Mn |
| Sep 30, 2025 | 17.55 Mn |
| Jun 30, 2025 | 19.00 Mn |
| Jun 30, 2025 | 19.00 Mn |
| Mar 31, 2025 | 29.84 Mn |
| Mar 31, 2025 | 29.84 Mn |
| Dec 31, 2024 | 27.20 Mn |
| Dec 31, 2024 | 27.20 Mn |
| Sep 30, 2024 | 18.03 Mn |
| Sep 30, 2024 | 18.03 Mn |
| Jun 30, 2024 | 20.25 Mn |
| Jun 30, 2024 | 20.25 Mn |
| Mar 31, 2024 | 14.71 Mn |
| Mar 31, 2024 | 14.71 Mn |